Compounds > n(6)-2-(4-amino-3-iodophenyl)ethyladenosine
Page last updated: 2024-09-03

n(6)-2-(4-amino-3-iodophenyl)ethyladenosine and zm 241385

n(6)-2-(4-amino-3-iodophenyl)ethyladenosine has been researched along with zm 241385 in 1 studies

Compound Research Comparison

Studies
(n(6)-2-(4-amino-3-iodophenyl)ethyladenosine)		Trials
(n(6)-2-(4-amino-3-iodophenyl)ethyladenosine)		Recent Studies (post-2010)
(n(6)-2-(4-amino-3-iodophenyl)ethyladenosine)		Studies
(zm 241385)		Trials
(zm 241385)		Recent Studies (post-2010) (zm 241385)
6004013124

Protein Interaction Comparison

ProteinTaxonomyn(6)-2-(4-amino-3-iodophenyl)ethyladenosine (IC50)zm 241385 (IC50)
Adenosine receptor A3Rattus norvegicus (Norway rat)0.0949
Adenosine receptor A2aHomo sapiens (human)0.0216
Adenosine receptor A2bHomo sapiens (human)0.0646

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brooks, R; Collis, MG; Keddie, JR; Poucher, SM; Shaw, GR1

Other Studies

1 other study(ies) available for n(6)-2-(4-amino-3-iodophenyl)ethyladenosine and zm 241385

ArticleYear
In vivo characterisation of ZM 241385, a selective adenosine A2A receptor antagonist.
    European journal of pharmacology, 1996, Apr-22, Volume: 301, Issue:1-3

    Topics: Adenosine; Animals; Cardiovascular Agents; Decerebrate State; Dogs; Female; Heart Rate; Hindlimb; In Vitro Techniques; Myocardial Contraction; Purinergic P1 Receptor Antagonists; Rats; Rats, Inbred SHR; Regional Blood Flow; Triazines; Triazoles; Vasodilation

1996